Adagio Medical Inc. (ADGM)
NASDAQ: ADGM
· Real-Time Price · USD
1.25
0.00 (0.38%)
At close: Aug 20, 2025, 3:59 PM
1.29
2.79%
After-hours: Aug 20, 2025, 05:31 PM EDT
Adagio Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Revenue | 42K | 296K | 322K | 543K | 399K | 145K | 179K | 101K | 60K | 60K | n/a |
Cost of Revenue | 1.47M | 1.8M | 2.09M | 2.13M | 1.81M | 1.13M | 905K | 862K | 609K | 609K | 291K |
Gross Profit | -1.42M | -1.51M | -1.77M | -1.59M | -1.41M | -984K | -726K | -761K | -549K | -549K | -291K |
Operating Income | -73.53M | -75.47M | -68.69M | -20.65M | -19.1M | -12.52M | -12.87M | -16.34M | -7.26M | -7.18M | -6.21M |
Interest Income | 432K | 330K | 167K | 168K | 2K | 462.36K | 462.36K | 465.36K | 465.36K | 5K | 4K |
Pretax Income | -58.72M | -61.23M | -53.76M | -5.32M | -19.69M | -12.85M | -12.44M | -16.25M | -5.49M | -5.87M | -6.03M |
Net Income | -60.86M | -57.62M | -50.16M | 426.33K | -13.94M | -12.85M | -12.44M | -16.25M | -5.49M | -5.87M | -6.03M |
Selling & General & Admin | 11.61M | 15.43M | 12.56M | 12.51M | 14.04M | 7.89M | 8.24M | 6.96M | 2.51M | 2.43M | 1.46M |
Research & Development | 10.26M | 11.16M | 10.97M | 9.32M | 12.53M | 9.66M | 10.99M | 13.67M | 9.25M | 9.25M | 4.45M |
Other Expenses | 50.76M | 50.76M | 50.61M | 6.05M | -52.86K | -52.86K | 97K | 4K | 4K | 4K | n/a |
Operating Expenses | 72.13M | 73.99M | 67.46M | 19.83M | 18.46M | 12.3M | 12.66M | 15.83M | 6.96M | 6.89M | 5.92M |
Interest Expense | 2.12M | 1.4M | 1.49M | 2.07M | 1.82M | 1.82M | 1.29M | 855K | 370K | 370K | 137K |
Selling & Marketing Expenses | 2.18M | 2.18M | 2.18M | n/a | 3.49M | 3.49M | 3.49M | 3.49M | n/a | n/a | n/a |
Cost & Expenses | 67.34M | 69.53M | 62.75M | 14.83M | 19.39M | 12.56M | 12.91M | 16.38M | 7.26M | 7.18M | 6.21M |
Income Tax Expense | 9.12M | 841.75K | n/a | -9.26M | -9.26M | -974.75K | -257K | -124K | -124K | -124K | n/a |
Shares Outstanding (Basic) | 15.38M | 15.38M | 14.87M | 14.54M | 7.66M | 7.78M | 7.93M | 13.39M | 7.43M | 15.06M | 19.19M |
Shares Outstanding (Diluted) | 15.38M | 15.38M | 14.87M | 14.54M | 7.66M | 7.78M | 7.93M | 13.39M | 7.43M | 15.06M | 19.19M |
EPS (Basic) | -4.63 | -4.46 | -3.99 | -0.72 | -1.2 | -1.06 | -1.02 | -1.05 | -0.25 | -0.3 | -0.31 |
EPS (Diluted) | -4.72 | -4.46 | -3.99 | -0.72 | -1.2 | -1.06 | -1.02 | -1.05 | -0.25 | -0.3 | -0.31 |
EBITDA | -72.02M | -73.71M | -74.8M | -21.27M | -27.91M | -21.59M | -19.63M | -22.64M | -12.37M | -12.29M | -5.76M |
EBIT | -70.87M | -74.3M | -74.51M | -26.38M | -31.57M | -24.91M | -26.69M | -24.02M | -14.94M | -14.94M | -5.89M |
Depreciation & Amortization | 951K | 1.21M | 1.27M | 976K | 720K | 463K | 257K | 259K | 259K | 259K | 135K |